Logo image of HYPR

HYPERFINE INC (HYPR) Stock Fundamental Analysis

USA - NASDAQ:HYPR - US44916K1060 - Common Stock

1.15 USD
+0.1 (+9.52%)
Last: 11/14/2025, 8:00:01 PM
1.15 USD
0 (0%)
After Hours: 11/14/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HYPR. HYPR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. HYPR has a great financial health rating, but its profitability evaluates not so good. HYPR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year HYPR has reported negative net income.
HYPR had a negative operating cash flow in the past year.
HYPR had negative earnings in each of the past 5 years.
HYPR had a negative operating cash flow in each of the past 5 years.
HYPR Yearly Net Income VS EBIT VS OCF VS FCFHYPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

HYPR has a Return On Assets of -87.01%. This is in the lower half of the industry: HYPR underperforms 75.66% of its industry peers.
With a Return On Equity value of -112.05%, HYPR is not doing good in the industry: 65.08% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -87.01%
ROE -112.05%
ROIC N/A
ROA(3y)-56.89%
ROA(5y)-47.09%
ROE(3y)-64.86%
ROE(5y)-52.85%
ROIC(3y)N/A
ROIC(5y)N/A
HYPR Yearly ROA, ROE, ROICHYPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Gross Margin of HYPR (45.80%) is comparable to the rest of the industry.
HYPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYPR Yearly Profit, Operating, Gross MarginsHYPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -2K -4K -6K

7

2. Health

2.1 Basic Checks

HYPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HYPR has been increased compared to 1 year ago.
There is no outstanding debt for HYPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HYPR Yearly Shares OutstandingHYPR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
HYPR Yearly Total Debt VS Total AssetsHYPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -5.91, we must say that HYPR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.91, HYPR is doing worse than 68.78% of the companies in the same industry.
HYPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.91
ROIC/WACCN/A
WACC8.78%
HYPR Yearly LT Debt VS Equity VS FCFHYPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

HYPR has a Current Ratio of 5.02. This indicates that HYPR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.02, HYPR is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
A Quick Ratio of 4.41 indicates that HYPR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.41, HYPR belongs to the top of the industry, outperforming 80.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.02
Quick Ratio 4.41
HYPR Yearly Current Assets VS Current LiabilitesHYPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.53% over the past year.
HYPR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.84%.
The Revenue has been growing by 105.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)16.84%
Revenue growth 3Y105.01%
Revenue growth 5YN/A
Sales Q2Q%-5.57%

3.2 Future

HYPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.04% yearly.
HYPR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.76% yearly.
EPS Next Y22.59%
EPS Next 2Y18.28%
EPS Next 3Y8.85%
EPS Next 5Y8.04%
Revenue Next Year5.2%
Revenue Next 2Y19.66%
Revenue Next 3Y16.27%
Revenue Next 5Y16.76%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HYPR Yearly Revenue VS EstimatesHYPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5M 10M 15M 20M 25M
HYPR Yearly EPS VS EstimatesHYPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HYPR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HYPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HYPR Price Earnings VS Forward Price EarningsHYPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYPR Per share dataHYPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.28%
EPS Next 3Y8.85%

0

5. Dividend

5.1 Amount

No dividends for HYPR!.
Industry RankSector Rank
Dividend Yield N/A

HYPERFINE INC

NASDAQ:HYPR (11/14/2025, 8:00:01 PM)

After market: 1.15 0 (0%)

1.15

+0.1 (+9.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-16 2026-03-16/amc
Inst Owners14.46%
Inst Owner Change1.9%
Ins Owners1.81%
Ins Owner Change-0.14%
Market Cap106.47M
Revenue(TTM)12.89M
Net Income(TTM)-39.36M
Analysts82.5
Price Target1.73 (50.43%)
Short Float %3.03%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.43%
Min EPS beat(2)-16.81%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-3.64%
Min EPS beat(4)-16.81%
Max EPS beat(4)1.96%
EPS beat(8)6
Avg EPS beat(8)2.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.73%
Min Revenue beat(2)-25.57%
Max Revenue beat(2)-11.9%
Revenue beat(4)1
Avg Revenue beat(4)-13.32%
Min Revenue beat(4)-25.57%
Max Revenue beat(4)8.33%
Revenue beat(8)3
Avg Revenue beat(8)-11.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20%
PT rev (3m)60.38%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)4.55%
EPS NY rev (1m)3.41%
EPS NY rev (3m)8.93%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-14.01%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.86
P/FCF N/A
P/OCF N/A
P/B 3.03
P/tB 3.03
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.12
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.01%
ROE -112.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.8%
FCFM N/A
ROA(3y)-56.89%
ROA(5y)-47.09%
ROE(3y)-64.86%
ROE(5y)-52.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 115.32%
Cap/Sales 10.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.02
Quick Ratio 4.41
Altman-Z -5.91
F-Score4
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)57.29%
Cap/Depr(5y)217.57%
Cap/Sales(3y)6.28%
Cap/Sales(5y)146.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
EPS Next Y22.59%
EPS Next 2Y18.28%
EPS Next 3Y8.85%
EPS Next 5Y8.04%
Revenue 1Y (TTM)16.84%
Revenue growth 3Y105.01%
Revenue growth 5YN/A
Sales Q2Q%-5.57%
Revenue Next Year5.2%
Revenue Next 2Y19.66%
Revenue Next 3Y16.27%
Revenue Next 5Y16.76%
EBIT growth 1Y5.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.71%
EBIT Next 3Y11.71%
EBIT Next 5YN/A
FCF growth 1Y8.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.28%
OCF growth 3YN/A
OCF growth 5YN/A

HYPERFINE INC / HYPR FAQ

What is the fundamental rating for HYPR stock?

ChartMill assigns a fundamental rating of 3 / 10 to HYPR.


What is the valuation status for HYPR stock?

ChartMill assigns a valuation rating of 0 / 10 to HYPERFINE INC (HYPR). This can be considered as Overvalued.


How profitable is HYPERFINE INC (HYPR) stock?

HYPERFINE INC (HYPR) has a profitability rating of 0 / 10.


Can you provide the financial health for HYPR stock?

The financial health rating of HYPERFINE INC (HYPR) is 7 / 10.


Can you provide the expected EPS growth for HYPR stock?

The Earnings per Share (EPS) of HYPERFINE INC (HYPR) is expected to grow by 22.59% in the next year.